Clinical Trial Update: Trilogy AB Acetabular Hip System Post Approval Study [Phase 4]

View source ↗

Summary

A Phase 4 post-approval study of the Trilogy AB Acetabular Hip System was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Osteoarthritis of the Hip
• Post-traumatic Arthritis of the Hip

Drugs mentioned

• Trilogy AB Acetabular Hip System

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Avascular Necrosis | Phase 4 | Status: TERMINATED | Results posted: 2014-11-26